Sökning: onr:"swepub:oai:DiVA.org:uu-268452" >
Home use of misopro...
Home use of misoprostol for early medical abortion in a low resource setting : secondary analysis of a randomized controlled trial
-
- Iyengar, Kirti (författare)
- Karolinska Institutet
-
- Klingberg-Allvin, Marie (författare)
- Högskolan Dalarna,Karolinska Institutet,Omvårdnad,Karolinska institutet
-
- Iyengar, Sharad D (författare)
- Action Research & Training for Health (ARTH), Satyam, Ramgiri, Badgaon, Udaipur, Rajasthan, India,Action for Reserach in Health (ARTH)
-
visa fler...
-
- Paul, Mandira, 1985- (författare)
- Uppsala universitet,Institutionen för kvinnors och barns hälsa,Internationell kvinno- & mödrahälsovård och migration/Essén,Uppsala Universitet
-
- Essén, Birgitta, 1961- (författare)
- Uppsala universitet,Institutionen för kvinnors och barns hälsa,Internationell kvinno- och mödrahälsovård och migration,Uppsala Universitet
-
- Gemzell-Danielsson, Kristina (författare)
- Karolinska Institutet
-
visa färre...
-
(creator_code:org_t)
- 2015-11-30
- 2016
- Engelska.
-
Ingår i: Acta Obstetricia et Gynecologica Scandinavica. - : Wiley. - 0001-6349 .- 1600-0412. ; 95:2, s. 173-181
- Relaterad länk:
-
https://obgyn.online...
-
visa fler...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
http://kipublication...
-
https://urn.kb.se/re...
-
visa färre...
Abstract
Ämnesord
Stäng
- INTRODUCTION: Although home use of misoprostol for early medical abortion is considered to be safe, effective and feasible, it has not become standard service delivery practice. The aim of this study was to compare the efficacy, safety, and acceptability of home use of misoprostol as compared to clinic misoprostol in a low-resource setting.MATERIAL AND METHODS: This was a secondary analysis of a randomised controlled trial conducted in 6 primary care clinics in India. Women seeking medical abortion up to 9 gestational weeks (n= 731) received mifepristone in the clinic, and were allocated either to home or clinic administration of misoprostol. Follow-up contact was after 10-15 days.RESULTS: Of 731 participants, 73% were rural and 55% had no formal education. Complete abortion rates in the home and clinic misoprostol groups were 94.2% and 94.4% respectively. The rate of adverse events was similar in both groups (0.3%). A greater proportion of home users (90.2%) said that they would opt for misoprostol at home in the event of a future abortion, than the proportion of clinic users (79.7%) that would opt for misoprostol at the clinic, in a similar situation (p=0.0002). Ninety six percent women using misoprostol at home or in the clinic were satisfied with their abortion experience.CONCLUSIONS: Home-use of misoprostol for early medical abortion is as effective and acceptable as clinic use, in low resource settings. Women should be offered a choice of this option regardless of distance of their residence from the clinic and communication facilities.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Reproduktionsmedicin och gynekologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Obstetrics, Gynaecology and Reproductive Medicine (hsv//eng)
- MEDICIN OCH HÄLSOVETENSKAP -- Hälsovetenskap -- Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Health Sciences -- Public Health, Global Health, Social Medicine and Epidemiology (hsv//eng)
Nyckelord
- Termination of pregnancy; home administration; mifepristone; misoprostol; medical abortion; low-resource setting; India
- Ökad tillgång till säker abortvård i Indien
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas